Effectiveness of monovalent XBB.1.5-containing Covid-19 mRNA vaccines in the Nordic countries

25/03/2024
10/06/2024
EU PAS number:
EUPAS1000000043
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Updated protocol

EMA_ROC17 Option_Study protocol .pdf

First published: 13/03/2024
English (662.84 KB - PDF) View document
Study results
Study report
Study report

EMA ROC17 Option Study report.pdf

English (1.26 MB - PDF) View document
Other information